These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 21460034)

  • 21. Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity.
    Ui A; Yasui A
    Nucleus; 2016 Apr; 7(2):138-45. PubMed ID: 27310306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output.
    Luo Z; Lin C; Guest E; Garrett AS; Mohaghegh N; Swanson S; Marshall S; Florens L; Washburn MP; Shilatifard A
    Mol Cell Biol; 2012 Jul; 32(13):2608-17. PubMed ID: 22547686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NUP98-MLL fusion in human acute myeloblastic leukemia.
    Kaltenbach S; Soler G; Barin C; Gervais C; Bernard OA; Penard-Lacronique V; Romana SP
    Blood; 2010 Sep; 116(13):2332-5. PubMed ID: 20558618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of MLL-associated leukemia.
    Yokoyama A
    Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ECSASB2 mediates MLL degradation during hematopoietic differentiation.
    Wang J; Muntean AG; Hess JL
    Blood; 2012 Feb; 119(5):1151-61. PubMed ID: 22174154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
    Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
    Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of transcriptional regulation by MLL and its disruption in acute leukemia.
    Dou Y; Hess JL
    Int J Hematol; 2008 Jan; 87(1):10-8. PubMed ID: 18224408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).
    Taki T; Shibuya N; Taniwaki M; Hanada R; Morishita K; Bessho F; Yanagisawa M; Hayashi Y
    Blood; 1998 Aug; 92(4):1125-30. PubMed ID: 9694699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
    Thiel AT; Blessington P; Zou T; Feather D; Wu X; Yan J; Zhang H; Liu Z; Ernst P; Koretzky GA; Hua X
    Cancer Cell; 2010 Feb; 17(2):148-59. PubMed ID: 20159607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.
    Yokoyama A; Lin M; Naresh A; Kitabayashi I; Cleary ML
    Cancer Cell; 2010 Feb; 17(2):198-212. PubMed ID: 20153263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biphasic MLL takes helm at cell cycle control: implications in human mixed lineage leukemia.
    Liu H; Takeda S; Cheng EH; Hsieh JJ
    Cell Cycle; 2008 Feb; 7(4):428-35. PubMed ID: 18235233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
    Yokoyama A
    Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of menin in hematopoiesis.
    Maillard I; Hess JL
    Adv Exp Med Biol; 2009; 668():51-7. PubMed ID: 20175452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The trithorax protein partner menin acts in tandem with EZH2 to suppress C/EBPα and differentiation in MLL-AF9 leukemia.
    Thiel AT; Feng Z; Pant DK; Chodosh LA; Hua X
    Haematologica; 2013 Jun; 98(6):918-27. PubMed ID: 23349306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
    Muntean AG; Tan J; Sitwala K; Huang Y; Bronstein J; Connelly JA; Basrur V; Elenitoba-Johnson KS; Hess JL
    Cancer Cell; 2010 Jun; 17(6):609-21. PubMed ID: 20541477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disordered epigenetic regulation in MLL-related leukemia.
    Zhang Y; Chen A; Yan XM; Huang G
    Int J Hematol; 2012 Oct; 96(4):428-37. PubMed ID: 23054645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7 and -A10 genes and induces apoptosis in a human leukemia cell line, THP-1.
    Kawagoe H; Kawagoe R; Sano K
    Leukemia; 2001 Nov; 15(11):1743-9. PubMed ID: 11681416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.
    Nguyen AT; Taranova O; He J; Zhang Y
    Blood; 2011 Jun; 117(25):6912-22. PubMed ID: 21521783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells.
    Joh T; Hosokawa Y; Suzuki R; Takahashi T; Seto M
    Oncogene; 1999 Jan; 18(4):1125-30. PubMed ID: 10023690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.
    Mohan M; Lin C; Guest E; Shilatifard A
    Nat Rev Cancer; 2010 Oct; 10(10):721-8. PubMed ID: 20844554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.